Tecan uses cookies to improve our website. By continuing to browse our website, you accept our cookie policy.
Prostate cancer is the second most common cancer in men, killing hundreds of thousands each year. However, the current routine screening method for checking prostate-specific antigen (PSA) levels generates false positives in an alarming number of...